Search results
Results from the WOW.Com Content Network
Anti-asthmatic agents, also known as anti-asthma drugs, refer to drugs that can aid in airway smooth muscle dilation to allow normal breathing during an asthma attack or reduce inflammation on the airway to decrease airway resistance for asthmatic patients, or both. The goal of asthmatic agents is to reduce asthma exacerbation frequencies and ...
GINA conducts continuous review of scientific publications on asthma and is a leader in disseminating information about the care of patients with asthma. [2] GINA publishes resources such as evidence-based guidelines for asthma management, and runs special events such as World Asthma Day. GINA's guidelines, revised each year, are used by ...
Asthma phenotyping and endotyping has emerged as a novel approach to asthma classification inspired by precision medicine which separates the clinical presentations of asthma, or asthma phenotypes, from their underlying causes, or asthma endotypes. The best-supported endotypic distinction is the type 2-high/type 2-low distinction.
Asthma & Allergy Friendly is a registered certification mark operated by Allergy Standards Limited [10] in association with not-for-profit asthma and/or allergy organizations in the country of operation. Products are subjected to standardised testing and if they pass, are deemed Asthma & Allergy Friendly.
The Journal of Asthma is a peer-reviewed medical journal that covers asthma and related conditions. ... This page was last edited on 12 January 2024, at 12:05 (UTC).
[5] [19] The Essential Medicines List (EML) was updated in July 2023 to its 23rd edition. This list contains 1200 recommendations for 591 drugs and 103 therapeutic equivalents. [20] A separate list for children up to 12 years of age, known as the WHO Model List of Essential Medicines for Children (EMLc), was created in 2007 and is in its 9th ...
Therapeutic Goods (Poisons Standard—October 2024) Instrument 2024; Department of Health and Aged Care; Citation: Link to instrument: Territorial extent: Australia: Enacted: 27 September 2024: Commenced: 1 October 2024: Authorizing legislation: Therapeutic Goods Act 1989: Repeals; Therapeutic Goods (Poisons Standard—June 2024) Instrument ...
In 2000-2001 asthma prevalence was monitored at 6.5%; by 2010-2011 a 4.3% increase was shown, with asthma prevalence totaling 10.8% of Canada's population. [ 29 ] Furthermore, asthma prevalence varies among the provinces of Canada; the highest prevalence is Ontario at 12.1%, and the lowest is Nunavut at 3.8%. [ 29 ]